PARIS The wide adoption of transcatheter aortic valve implantation (TAVI) techniques is funding an impressive industrial effort to fix the flaws in first generation devices.

PARIS While cardiologists play coy about their interest in taking up the new procedure for renal denervation, industry is running at full steam toward what can only be described a massive market opportunity.

PARIS Champagne was served all around, even for journalists, to celebrate the tenth anniversary of the first transcatheter valve implantation (TAVI) in May, 2002 in Rouen, France.